Stathmin-Deficient Mice Develop an Age-Dependent Axonopathy of the Central and Peripheral Nervous Systems

The American Journal of Pathology - Tập 160 - Trang 469-480 - 2002
Wolfgang Liedtke1, Elizabeth E. Leman2, Robert E.W. Fyffe2, Cedric S. Raine1, Ulrich K. Schubart3,4
1Department of Pathology, College of Medicine, Bronx, New York
2Department of Anatomy, Wright State University, Dayton, Ohio
3Department of Medicine, College of Medicine, Bronx, New York
4Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York

Tài liệu tham khảo

Schubart, 1996, Normal development of mice lacking metablastin (P19), a phosphoprotein implicated in cell cycle regulation, J Biol Chem, 271, 14062, 10.1074/jbc.271.24.14062 Sobel, 1989, Intracellular substrates for extracellular signaling: characterization of a ubiquitous, neuron-enriched phosphoprotein (stathmin), J Biol Chem, 264, 3765, 10.1016/S0021-9258(19)84915-3 Pasmantier, 1986, p19, a hormonally regulated phosphoprotein of peptide hormone-producing cells: secretagogue-induced phosphorylation in AtT-20 mouse pituitary tumor cells and in rat and hamster insulinoma cells, Endocrinology, 119, 1229, 10.1210/endo-119-3-1229 Cooper, 1989, Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin, J Immunol, 143, 956, 10.4049/jimmunol.143.3.956 Ferrari, 1990, A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35–36.1, Genes Chromosom Cancer, 2, 125, 10.1002/gcc.2870020208 Melhem, 1991, Involvement of Op18 in cell proliferation, Biochem Biophys Res Comm, 179, 1649, 10.1016/0006-291X(91)91764-4 Schubart, 1992, Widespread, differentiation stage-specific expression of the gene encoding phosphoprotein p19 (Metablastin) in mammalian cells, Differentiation, 51, 21, 10.1111/j.1432-0436.1992.tb00676.x Brattsand, 1993, Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells, Leukemia, 7, 569 Horwitz, 1997, The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation, J Biol Chem, 272, 8129, 10.1074/jbc.272.13.8129 Schubart, 1988, Expression of phosphoprotein p19 in brain, testis, and neuroendocrine tumor cells. Developmental regulation in rat brain, J Biol Chem, 263, 12156, 10.1016/S0021-9258(18)37907-9 Koppel, 1990, Developmental tissue expression and phylogenetic conservation of stathmin, a phosphoprotein associated with cell regulations, J Biol Chem, 265, 3703, 10.1016/S0021-9258(19)39651-6 Amat, 1991, Distribution of phosphoprotein p19 in rat brain during ontogeny: stage-specific expression in neurons and glia, Brain Res Dev Brain Res, 60, 205, 10.1016/0165-3806(91)90049-O Amat, 1990, Stage-specific expression of phosphoprotein p19 during spermatogenesis in the rat, Mol Reprod Dev, 26, 383, 10.1002/mrd.1080260414 Strahler, 1992, Cell cycle progression is associated with distinct patterns of phosphorylation of Op18, Biochem Biophys Res Commun, 185, 197, 10.1016/S0006-291X(05)80975-1 Luo, 1994, Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase, J Biol Chem, 269, 10312, 10.1016/S0021-9258(17)34062-0 Brattsand, 1994, Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38, Eur J Biochem, 220, 359, 10.1111/j.1432-1033.1994.tb18632.x Marklund, 1994, The phenotype of a Cdc2 kinase target site-deficient mutant of oncoprotein 18 reveals a role of this protein in cell cycle control, J Biol Chem, 269, 30626, 10.1016/S0021-9258(18)43860-4 Larsson, 1995, G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems, J Biol Chem, 270, 14175, 10.1074/jbc.270.23.14175 Hanash, 1988, Identification of a polypeptide associated with the malignant phenotype in acute leukemia, J Biol Chem, 263, 12813, 10.1016/S0021-9258(18)37630-0 Roos, 1993, Expression of oncoprotein 18 in human leukemias and lymphomas, Leukemia, 7, 1538 Nylander, 1995, Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas, Histochem J, 27, 155, 10.1007/BF00243911 Friedrich, 1995, Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma, Prostate, 27, 102, 10.1002/pros.2990270207 Bieche, 1998, Overexpression of the stathmin gene in a subset of human breast cancer, Br J Cancer, 78, 701, 10.1038/bjc.1998.565 Himi, 1994, Differential localization of SCG10 and p19/stathmin messenger RNAs in adult rat brain indicates distinct roles for these growth-associated proteins, Neuroscience, 60, 907, 10.1016/0306-4522(94)90271-2 Sugiura, 1995, SCG10 expresses growth-associated manner in developing rat brain, but shows a different pattern to p19/stathmin or GAP-43, Brain Res Dev Brain Res, 90, 73, 10.1016/0165-3806(96)83488-2 Belmont, 1996, Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules, Cell, 84, 623, 10.1016/S0092-8674(00)81037-5 Larsson, 1997, Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis, Mol Cell Biol, 17, 5530, 10.1128/MCB.17.9.5530 Curmi, 1997, The stathmin/tubulin interaction in vitro, J Biol Chem, 272, 25029, 10.1074/jbc.272.40.25029 Jourdain, 1997, Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules, Biochemistry, 36, 10817, 10.1021/bi971491b Howell, 1999, Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin, Mol Biol Cell, 10, 105, 10.1091/mbc.10.1.105 Marklund, 1996, Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics, EMBO J, 15, 5290, 10.1002/j.1460-2075.1996.tb00914.x Melander Gradin, 1997, Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18, Mol Cell Biol, 17, 3459, 10.1128/MCB.17.6.3459 Schubart, 1989, Homology between the cDNAs encoding phosphoprotein p19 and SCG10 reveals a novel mammalian gene family preferentially expressed in developing brain, DNA, 8, 389, 10.1089/dna.1.1989.8.389 Zhu, 1989, Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species, J Biol Chem, 264, 14556, 10.1016/S0021-9258(18)71714-6 Doye, 1989, A single cDNA encodes two isoforms of stathmin, a developmentally regulated neuron-enriched phosphoprotein, J Biol Chem, 264, 12134, 10.1016/S0021-9258(18)63830-X Melhem, 1991, Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia, J Biol Chem, 266, 17747, 10.1016/S0021-9258(18)55189-9 Maucuer, 1993, Stathmin gene family: phylogenetic conservation and developmental regulation in Xenopus, J Biol Chem, 268, 16420, 10.1016/S0021-9258(19)85437-6 Okazaki, 1993, Molecular diversity of the SCG10/stathmin gene family in the mouse, Genomics, 18, 360, 10.1006/geno.1993.1477 Ozon, 1997, The stathmin family: molecular and biological characterization of novel mammalian proteins expressed in the nervous system, Eur J Biochem, 248, 794, 10.1111/j.1432-1033.1997.t01-2-00794.x Ozon, 1998, SCLIP: a novel SCG10-like protein of the stathmin family expressed in the nervous system, J Neurochem, 70, 2386, 10.1046/j.1471-4159.1998.70062386.x Brown, 1982, Chronic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse, Lab Invest, 46, 171 Boer, 1990, Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles, Biochem Genet, 28, 299, 10.1007/BF02401419 Liedtke, 1998, Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion, Am J Pathol, 152, 251 Liedtke, 1996, GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination, Neuron, 17, 607, 10.1016/S0896-6273(00)80194-4 Raine, 1979, Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures, Lab Invest, 40, 423 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 Liedtke, 2000, Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor, Cell, 103, 525, 10.1016/S0092-8674(00)00143-4 Hirano, 1991, Cytopathology of amyotrophic lateral sclerosis, 91 Xu, 1993, Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease, Cell, 73, 23, 10.1016/0092-8674(93)90157-L Cote, 1993, Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis, Cell, 73, 35, 10.1016/0092-8674(93)90158-M Zhang, 1997, Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation, J Cell Biol, 139, 1307, 10.1083/jcb.139.5.1307 Charbaut, 2001, Stathmin family proteins display specific molecular and tubulin binding properties, J Biol Chem, 276, 16146, 10.1074/jbc.M010637200 Peters, 1981, Central nervous system, 1 Spencer, 1981, The mammalian peripheral nervous system in old age, 35 Elder, 1999, Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit, J Cell Biol, 146, 181, 10.1083/jcb.146.1.181 Giese, 1992, Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons, Cell, 71, 565, 10.1016/0092-8674(92)90591-Y Bronson, 1992, Genetic and age related models of neurodegeneration in mice: dystrophic axons, J Neurogenet, 8, 71, 10.3109/01677069209084153 Boison, 1994, Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice, Proc Natl Acad Sci USA, 91, 11709, 10.1073/pnas.91.24.11709 Schrank, 1997, Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos, Proc Natl Acad Sci USA, 94, 9920, 10.1073/pnas.94.18.9920 Reaume, 1996, Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nat Genet, 13, 43, 10.1038/ng0596-43 Rowland, 1991, Amyotrophic lateral sclerosis and other motor neuron diseases, Vol. 56, 569 Stein, 1988, The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons, Neuron, 1, 463, 10.1016/0896-6273(88)90177-8 Matsuo, 1998, A novel SCG10-related gene uniquely expressed in the nervous system, Gene, 215, 477, 10.1016/S0378-1119(98)00324-2 Chen, 1999, Subtractive cDNA cloning and characterization of genes induced by all-trans retinoic acid, Ann NY Acad Sci, 886, 225, 10.1111/j.1749-6632.1999.tb09422.x Velculescu, 2000, Analysing uncharted transcriptomes with SAGE, Trends Genet, 16, 423, 10.1016/S0168-9525(00)02114-4 Serafini, 1999, Of neurons and gene chips, Curr Opin Neurobiol, 9, 641, 10.1016/S0959-4388(99)00022-7